NDC 0061-0100 - Gentocin Durafilm
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-0100
- Package NDCs from labels
- 0061-0100-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2024-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gentocin Durafilm - Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp. | 2024-11-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-0100-01 | Gentocin Durafilm | 1 in 1 CARTON | SOLUTION | 1 | 6 | |
| 0061-0100-01 | Gentocin Durafilm | 5 mL in 1 BOTTLE, DROPPER | SOLUTION | 5 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BETAMETHASONE ACETATE | ACTIVE INGREDIENT | TI05AO53L7 | GENTOCIN DURAFILM (GENTAMICIN SULFATE AND BETAMETHASONE ACETATE) SOLUTION [MERCK SHARP & DOHME CORP.] | 1 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTOCIN DURAFILM (GENTAMICIN SULFATE AND BETAMETHASONE ACETATE) SOLUTION [MERCK SHARP & DOHME CORP.] | 1 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | GENTOCIN DURAFILM (GENTAMICIN SULFATE AND BETAMETHASONE ACETATE) SOLUTION [MERCK SHARP & DOHME CORP.] | 1 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTOCIN DURAFILM (GENTAMICIN SULFATE AND BETAMETHASONE ACETATE) SOLUTION [MERCK SHARP & DOHME CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | 8X7386QRLV |
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 2023-12-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Hikma Pharmaceuticals USA Inc. | 51fffac8-fb6e-4f7f-b2de-440252781a42 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | A-S Medication Solutions | 76fabcd6-4da3-49e3-85a1-ca4fac55a207 | 2023-05-08 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | a8b15217-cccb-2260-e053-2995a90a709d | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | 4cfbe37e-11d6-46fc-b287-0561387b17b7 | 2023-01-31 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate in Sodium Chloride | GENTAMICIN SULFATE | Baxter Healthcare Corporation | 449c9a41-d61e-49fd-b5e3-d76f74b92acf | 2023-01-26 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.